Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Barfresh Announces Second Quarter 2025 Results
-
Inhibrx Reports Second Quarter 2025 Financial Results
-
Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update
-
Helen of Troy Limited Announces G. Scott Uzzell Appointed to Become Chief Executive Officer
-
Spire Global Announces Preliminary Second Quarter 2025 Revenue and Provides Business Update
-
Carlisle Companies Publishes 2024 Corporate Sustainability Report
-
Resideo Announces Completion of Transaction with Honeywell To Accelerate Payment of All Potential Monetary Obligations Under Indemnification and Reimbursement Agreement
-
AirJoule Technologies Announces Second Quarter 2025 Results
-
Five Below, Inc. Announces Second Quarter 2025 Earnings Release and Conference Call Date
-
Fossil Group, Inc. Announces ABL Refinancing and Transaction Support Agreement for Debt Exchange
-
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Accelerant Announces Date of Second Quarter 2025 Financial Results and Conference Call
-
Highview Merger Corp. Announces Completion of $230,000,000 Initial Public Offering
-
Hyperfine, Inc. Reports Second Quarter 2025 Financial Results
-
STRATA Skin Sciences Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
-
Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update
-
Corpay to Participate in Upcoming Investor Conferences
-
The Oncology Institute Reports Second Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance
-
Coherent Corp. Reports Fourth Quarter and Full Year Fiscal 2025 Results
-
HeartCore Reports Financial Results for Second Quarter and Six Months Ended June 30, 2025
-
Roadzen Reports Best Fiscal Q1 in Company History with 22% Revenue Growth, 92% Lower Net Loss, and 50% Adjusted EBITDA Improvement Over the Same Quarter Last Year
-
Immuneering Reports Second Quarter 2025 Financial Results and Provides Business Updates
-
Allogene Therapeutics Reports Second Quarter 2025 Financial Results and Business Update
-
Expion360 Reports Second Quarter 2025 Financial and Operational Results
-
Robinhood Markets, Inc. Reports July 2025 Operating Data
-
Tenon Medical Reports Second Quarter 2025 Financial Results
-
Dynagas LNG Partners LP Announces Cash Distribution for the Quarter Ended June 30, 2025 of $0.049 Per Unit
-
Vox Royalty Announces Q2 2025 Financial Results and Declares Quarterly Dividend
-
The Oncology Institute Announces Changes to Board of Directors
-
National Organization for Rare Disorders (NORD) Announces Annual Seed Grant RFPs Totaling $245,000 to Accelerate Research for Five Rare Diseases
-
Xos Hits New Milestones in Q2 2025 with Highest Revenue and Deliveries in the Company’s History
-
Epsilon Announces Second Quarter 2025 Results and Transformative Acquisitions in the Powder River Basin
-
Epsilon Announces Second Quarter 2025 Results and Transformative Acquisitions in the Powder River Basin
-
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HanesBrands Inc. (NYSE - HBI), Sapiens International Corporation N.V. (Nasdaq – SPNS), American Woodmark Corp
-
Destination XL Group, Inc. to Announce Second Quarter 2025 Financial Results on Wednesday, August 27, 2025
-
Real Estate Expert Sabre Cofer Shares Key Advice on Buying a Home in Amarillo, As Written in HelloNation
-
Conifer Holdings Reports 2025 Second Quarter Financial Results
-
Dyadic Reports Second Quarter 2025 Financial Results and Highlights of Recent Company Progress
-
IM Cannabis Announces Warrant Amendments and Form F-3 Resale Registration Statement Filing
-
HeartBeam Reports Second Quarter 2025 Results
-
MacroGenics Appoints Eric Risser as President and Chief Executive Officer
-
Elcora Provides Update on Status of Management Cease Trade Order
-
Kezar Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update
-
Coherent Announces Agreement to Sell Aerospace and Defense Business to Advent for $400 Million
-
Arcos Dorados to Participate in Upcoming Investor Events
-
Hyperion DeFi Provides Corporate Update and Reports Second Quarter 2025 Financial Results
-
MacroGenics Appoints Eric Risser as President and Chief Executive Officer
-
Coherent Announces Agreement to Sell Aerospace and Defense Business to Advent for $400 Million
-
Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains
-
Birchcliff Energy Ltd. Announces Q2 2025 Results, Strong New Well Performance and Declares Q3 2025 Dividend
